| ECAT | XRLX | ECAT / XRLX | |
| Gain YTD | 11.260 | 7.554 | 149% |
| Net Assets | 1.57B | 51M | 3,082% |
| Total Expense Ratio | 1.30 | 1.20 | 108% |
| Turnover | 226.00 | 84.00 | 269% |
| Yield | 1.37 | 2.57 | 53% |
| Fund Existence | 5 years | 24 years | - |
| ECAT | XRLX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 72% | 2 days ago 58% |
| Stochastic ODDS (%) | 1 day ago 80% | 2 days ago 78% |
| Momentum ODDS (%) | 1 day ago 85% | 2 days ago 88% |
| MACD ODDS (%) | 1 day ago 78% | 2 days ago 65% |
| TrendWeek ODDS (%) | 1 day ago 76% | 2 days ago 84% |
| TrendMonth ODDS (%) | 1 day ago 86% | 2 days ago 84% |
| Advances ODDS (%) | 9 days ago 83% | 9 days ago 82% |
| Declines ODDS (%) | 16 days ago 79% | 7 days ago 58% |
| BollingerBands ODDS (%) | 1 day ago 76% | 2 days ago 55% |
| Aroon ODDS (%) | 1 day ago 90% | 2 days ago 83% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNIX | 84.18 | 1.02 | +1.23% |
| Janus Henderson Global Life Sciences I | |||
| VEIGX | 42.40 | N/A | N/A |
| Vanguard Global ESG Select Stk Investor | |||
| HNDDX | 83.86 | N/A | N/A |
| Horizon Equity Premium Income Investor | |||
| CGFAX | 83.89 | -1.87 | -2.18% |
| American Funds Growth Fund of Amer 529A | |||
| AGGRX | 10.84 | -0.30 | -2.69% |
| American Century Focused Global Gr A | |||
A.I.dvisor indicates that over the last year, ECAT has been loosely correlated with BSX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ECAT jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To ECAT | 1D Price Change % | ||
|---|---|---|---|---|
| ECAT | 100% | -0.71% | ||
| BSX - ECAT | 64% Loosely correlated | +2.86% | ||
| CRM - ECAT | 62% Loosely correlated | +2.20% | ||
| AMT - ECAT | 56% Loosely correlated | +1.67% | ||
| NEE - ECAT | 55% Loosely correlated | +0.41% | ||
| MSFT - ECAT | 12% Poorly correlated | +1.80% | ||
More | ||||